Dear all,
The attached article was on the BBC website today.
The drug is not currently used for MS but Dacluzimab which is also an anti-transplant rejection drug is in trial. The moral of the story is that while you can affect the immune system by using heavy duty drugs there is always a price to pay - in this story the price is skin cancer. We are now aware of bad side effects (including death) from heavy immune suppressing drugs such as Tysabri and Campath. Hopefully future treatments will be more focused and not wreck the entire immune system. Tovaxin looks more promising in this respect.
http://news.bbc.co.uk/1/hi/health/4248356.stm
Bromley
Immune system
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1330 Views
-
Last post by NHE
-
- 0 Replies
- 448 Views
-
Last post by DIM
-
- 1 Replies
- 1056 Views
-
Last post by 1eye
-
- 0 Replies
- 1011 Views
-
Last post by frodo
-
- 2 Replies
- 1393 Views
-
Last post by vesta
-
- 0 Replies
- 1535 Views
-
Last post by sk04g
-
- 0 Replies
- 1132 Views
-
Last post by Petr75
-
- 3 Replies
- 4401 Views
-
Last post by NHE
-
- 61 Replies
- 12438 Views
-
Last post by jimmylegs